சர்வதேச தரநிலை ஆன் விமர்சனம் ஈடுபாடுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சர்வதேச தரநிலை ஆன் விமர்சனம் ஈடுபாடுகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சர்வதேச தரநிலை ஆன் விமர்சனம் ஈடுபாடுகள் Today - Breaking & Trending Today

Hyloris Reports 2021 Half-Year Results: Multiple Potential Value Inflection Points Ahead


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Hyloris Reports 2021 Half-Year Results: Multiple Potential Value Inflection Points Ahead
Hyloris Pharmaceuticals SAAugust 4, 2021 GMT
 On target to grow the broad product pipeline with at least 3 additional programmes before end 2021
Significant expansion of commercial footprint of non-opioid pain treatment Maxigesic® IV
Expected to start 2 clinical studies and to report the results from 2 clinical studies before year-end
€53.47 million in cash and cash equivalents to execute ambitious growth strategy
Conference call and webcast today at 3pm CEST/9am EST (details below)
Liège, Belgium – 4 August 2021 – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, today reports its condensed consolidated financial results for the six-month p ....

United States , United Kingdom , Marieke Vermeersch , Stijn Van Rompay , Miconazole Domiphen , Olivier Declercq , Chris Buyse , Alter Pharma Group For Maxigesic , Alter Pharma Group , International Standard On Review Engagements , Hyloris Pharmaceuticals , Company Group Structure , Hyloris Pharmaceuticals Sa Euronext Brussels , Corporate Communications , Pharma Bavaria International , Hikma Pharmaceuticals , Euronext Brussels , Van Rompay , Chief Executive Officer , South America , Latin America , Purna Female Healthcare , Miconazole Domiphen Bromide , Tranexamic Acid , Fusidic Acid , Alter Pharma ,

Senior PLC (LSE:SNR) | RNS | Senior PLC - Interim Results


£50m for the full year


Commenting on the results,
David Squires, Group Chief Executive Officer of Senior plc, said:
Our performance in the first half of 2021 has, once again, demonstrated the resilience of Senior.  While the global pandemic is not over, we are encouraged to see the clear signs of recovery in our end markets, which gives renewed confidence in our ability to create enhanced value for our investors over the medium term.  As we said in our
9 July 2021 Post-Close Trading Update, for 2021, despite the well-publicised headwinds associated with freight and commodity costs; semiconductor supply chain challenges for our land vehicle customers; as well as the divestment of our Senior Aerospace Connecticut business, we expect overall Group performance for 2021 to be slightly ahead of our previous expectations.  In relative terms, H1 2021 is likely to be slightly stronger than H2 2021 due to reduced defence sales in H2 2021, which, based ....

United States , United Kingdom , South Africa , City Of , South Carolina , Susan Brennan , Finsbury Glover Hering , David Squires , Gulshen Patel , Robert Brent , Richard Webster Smith , Flexonics Upeca , Flexonics Division , United Kingdom Financial Conduct Authority , Group Annual Financial , Registrar Of Companies , Senior Aerospace Connecticut See , Calorstat French Aerospace , International Standards On Auditing , Oil Market Report , London Stock Exchange , Senior Aerospace Connecticut , Civil Aerospace , Bloom Energy Corporation , Senior Managers Of The Group , Financial Statements Of The Group ,